Skip to content

Clinical trials

Completed Phase 2 Parkinsonian Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Phase: Phase 2 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20062
20101
20111
20122
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute for Neurodegenerative Disorders6
Novartis Pharmaceuticals3
Chang Gung Memorial Hospital1
National Institute of Neurological Disorders and Stroke (NINDS)1
Ron Postuma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinsonian Disorders12
Parkinson Disease8
Disease5
Movement Disorders4
Dyskinesias3
Neurodegenerative Diseases2
Basal Ganglia Diseases1
Brain Diseases1
Central Nervous System Diseases1
Nervous System Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.